MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats

Physiological Genomics

Volumn 43, Issue 11, 2011, Pages 665-673

  Soci, U P R ^a   Fernandes, T ^a   Hashimoto, N Y ^a   Mota, G F ^a   Amadeu, M A ^a   Rosa, K T ^a   Irigoyen, M C ^a   Phillips, M I ^b   Oliveira, E M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b KECK GRADUATE INSTITUTE   (United States)

Author keywords

Cardiac hypertrophy; Collagen; Diastolic function; Molecular markers; Physiological cardiac hypertrophy; Swimming training

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; COLLAGEN TYPE 1; COLLAGEN TYPE 3; HYDROXYPROLINE; MESSENGER RNA; MICRORNA; MICRORNA 29; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; UNCLASSIFIED DRUG;

AEROBIC CAPACITY; AEROBIC EXERCISE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; GENE EXPRESSION; HEART; HEART FUNCTION; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART RATE; HEART VENTRICLE COMPLIANCE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; MICROARRAY ANALYSIS; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; SEDENTARY LIFESTYLE; SWIMMING; TREADMILL EXERCISE; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CITRATE (SI)-SYNTHASE; FEMALE; GENETIC MARKERS; HEART VENTRICLES; HYDROXYPROLINE; MICRORNAS; MYOCYTES, CARDIAC; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT;

RATTUS; RATTUS NORVEGICUS;

EID: 79959312396     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00145.2010     Document Type: Article

References (40)

1. Bergman I, Loxley R. New spectrophotometric method for the determination of proline in tissue hydrolyzates. Anal Chem 42: 702-706, 1970.
2. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P, Bang ML, Segnalini P, Gu Y, Dalton ND, Elia L, Latronico MV, Høydal M, Autore C, Russo MA, Dorn GW 2nd, Ellingsen O, Ruiz-Lozano P, Peterson KL, Croce CM, Peschle C, Condorelli G. MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618, 2007.
3. Catalucci D, Gallo P, Condorelli G. MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet 2: 402-408, 2009.
4. Chen CH, Zhou YL, Wu YF, Cao Y, Gao JS, Tang JB. Effectiveness of microRNA in Down-regulation of TGF-beta gene expression in digital flexor tendons of chickens: in vitro and in vivo study. J Hand Surg Am 34: 1777-1784. e.1, 2009.
5. Chien KR, Knowlton KU, Zhu H, Chien S. Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiological response. FASEB J 5: 3037-3046, 1991.
6. Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van-Bilsen M, O'Brien TX, Evans SM. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol 55: 77-95, 1993.
7. Crimi E, Ignarro LJ, Cacciatore F, Napoli C. Mechanisms by which exercise training benefits patients with heart failure. Nat Rev Cardiol 6: 292-300, 2009.
8. DeBosch B, Treskov I, Lupu TS, Weinheimer C, Kovacs A, Courtois M, Muslin AJ. Akt1 is required for physiological cardiac growth. Circulation 113: 2097-2104, 2006.
9. Drummond MJ, Mccarthy JJ, Fry CS, Esser KA, Rasmussen BB. Aging differentially affects human skeletal muscle microRNA expression at rest and following resistance exercise and essential amino acid inges-tion. Am J Physiol Endocrinol Metab 295: E1333-E1340, 2008.
10. Du B, Ma LM, Huang MB, Zhou H, Huang HL, Shao P, Chen YQ, Qu LH. High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells. FEBS Lett 584: 811-816, 2010.
11. Evangelista FS, Brum PC, Krieger JE. Duration-controlled swimming exercise training induces cardiac hypertrophy in mice. Braz J Med Biol Res 36: 1751-1759, 2003.
12. Ferreira JC, Rolim NP, Bartholomeu JB, Gobatto CA, Kokubun E, Brum PC. Maximal lactate steady state in running mice: effect of exercise training. Clin Exp Pharmacol Physiol 34: 760-765, 2007.
13. Gunja-Smith Z, Lin J, Woessner JF Jr. Changes in desmosine and pyridinoline crosslinks during rapid synthesis and degradation of elastin and collagen in the rat uterus. Matrix 9: 21-27, 1989.
14. Heineke J, Molkentin JD. Regulation of cardiac hypertrophy by intra-cellular signaling pathways. Nat Rev Mol Cell Biol 7: 589-600, 2006.
15. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Kobayashi T, Fujii N, Miyazaki H, Matsuda M, Yamaguchi I. Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am J Physiol Regul Integr Comp Physiol 281: R2029-R2036, 2001.
16. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci USA 85: 339-343, 1988.
17. Kemi OJ, Ceci M, Wisloff U, Grimaldi S, Gallo P, Smith GL, Condorelli G, Ellingsen O. Activation or inactivation of cardiac Akt/ mTOR signaling diverges physiological from pathological hypertrophy. J Cell Physiol 214: 316-321, 2008.
18. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385, 2005.
19. Latronico MV, Condorelli G. MicroRNAs and cardiac pathology. Nat Rev Cardiol 6: 419-429, 2009.
20. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN. MicroRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22: 3242-3254, 2008.
21. Luo J, McMullen JR, Sobkiw CL, Zhang L, Dorfman AL, Sherwood MC, Logsdon MN, Horner JW, DePinho RA, Izumo S, Cantley LC. Class IA phosphoinositide 3-kinase regulates heart size and physiological cardiac hypertrophy. Mol Cell Biol 25: 9491-9502, 2005.
22. Maurer B, Stanczyk J, Jüngel A, Akhmetshina A, Trenkmann M, Brock M, Kowal-Bielecka O, Gay RE, Michel BA, Distler JH, Gay S, Distler O. MicroRNA-29, a key regulator of collagen expression in systemic sclerosis. Arthritis Rheum 62: 1733-1743, 2010.
23. McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, Hewitt KA, Mollica JP, Zhang L, Zhang Y, Shioi T, Buerger A, Izumo S, Jay PY, Jennings GL. Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104: 612-617, 2007.
24. McMullen JR, Jennings GL. Differences between pathological and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clin Exp Pharmacol Physiol 34: 255-262, 2007.
25. McMullen JR, Shioi T, Zhang L, Tarnavski O, Sherwood MC, Kang PM, Izumo S. Phosphoinositide 3-kinase (p110alpha) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc Natl Acad Sci USA 100: 12355-12360, 2003.
26. Medeiros A, Oliveira EM, Gianolla R, Casarini DE, Negrão CE, Brum PC. Swimming training increases cardiac vagal activity and induces cardiac hypertrophy in rats. Braz J Med Biol Res 37: 1909-1917, 2004.
27. Oliveira EM, Sasaki MS, Cerêncio M, Baraúna VG, Krieger JE. Local renin-angiotensin system regulates left ventricular hypertrophy induced by swimming training independent of circulating renin: a pharmacological study. J Renin Angiotensin Aldosterone Syst 10: 15-23, 2009.
28. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978.
29. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416-424, 2007.
30. Srere PA. Studies on purified citrate-enzymes: metabolic interpretations. Biochem Soc Symp 27: 11-21, 1968.
31. Takaya T, Ono K, Kawamura T, Takanabe R, Kaichi S, Morimoto T, Wada H, Kita T, Shimatsu A, Hasegawa K. MicroRNA-1 and MicroRNA-133 in spontaneous myocardial differentiation of mouse embryonic stem cells. Circ J 73: 1492-1497, 2009.
32. Urhausen A, Kindermann W. Sports-specific adaptations and differentiation of the athlete's heart. Sports Med 4: 237-244, 1999.
33. van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease. Circ Res 103: 919-928, 2008.
34. van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest 117: 2369-2376, 2007.
35. van Rooij E, Sutherland LB, Liu N, Willians AH, Macanally Gerard RD J, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260, 2006.
36. van Rooij E, Sutherland LB, Qi X, Richardson JA, Hill J, Olson EN. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316: 575-579, 2007.
37. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032, 2008.
38. Vollaard NB, Constantin-Teodosiu D, Fredriksson K, Rooyackers O, Jansson E, Greenhaff PL, Timmons JA, Sundberg CJ. Systematic analysis of adaptations in aerobic capacity and submaximal energy metabolism provides a unique insight into determinants of human aerobic performance. J Appl Physiol 106: 1479-1486, 2009.
39. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849-1865, 1991.
40. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-220, 2005.